268
Views
16
CrossRef citations to date
0
Altmetric
Letter to the Editor

Efficacy of ibrutinib as first-line treatment of tumoral Bing–Neel syndrome

ORCID Icon, , , &
Pages 2746-2748 | Received 04 Sep 2017, Accepted 04 Feb 2018, Published online: 23 Mar 2018
 

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at https://doi.org/10.1080/10428194.2018.1441409.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.